Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02157974 · ClinicalTrials.gov registry record · Phase 2
Liver and Fat Regulation in Overweight Adolescent Girls
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT02157974 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 92 participants.
The verdict
NCT02157974, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
Women with polycystic ovarian syndrome (PCOS) have increased rates of hepatic steatosis compared to weight similar women with regular menses. It is unclear if this is related to high testosterone or insulin resistance. The investigators will assess hepatic glucose release, rates of lipolysis and hepatic de novo lipogenesis in the fasted and postprandial state to determine if alterations in the processes contribute to hepatic steatosis. Participants will be overweight, sedentary girls with or without PCOS. Those with PCOS will either be medication naive, or must be taking metformin or combined oral contraceptives (COCPs) for a period of at least 6 months prior to study procedures.
Interventions
- DRUG Byetta 5Mcg Pen Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2014-08 |
| Est. Completion | 2022-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02157974
The ClinicalTrials.gov registry entry for NCT02157974 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Byetta 5Mcg Pen Injection is the first listed.
NCT02157974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02157974 about?
NCT02157974 is a clinical study titled "Liver and Fat Regulation in Overweight Adolescent Girls". Women with polycystic ovarian syndrome (PCOS) have increased rates of hepatic steatosis compared to weight similar women with regular menses. It is unclear if this is related to high testosterone or insulin resistance. The investigators will assess hepatic glucose release, rates of lipolysis and hep...
What is the current status of trial NCT02157974?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2014-08. Estimated completion is 2022-12.
What interventions are being tested in trial NCT02157974?
The interventions under investigation include: Byetta 5Mcg Pen Injection (DRUG).
Who is sponsoring clinical trial NCT02157974?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.